Mass General Brigham names Paul Anderson Chief Academic Officer
2023-10-24
(Press-News.org) Following a national search, Paul Anderson, MD, PhD, has been named Chief Academic Officer for Mass General Brigham. Anderson, who has been serving in this role on an interim basis since January 1, oversees Mass General Brigham’s world-class research and teaching enterprise, which includes two academic medical centers — Mass General Hospital and Brigham and Women’s Hospital — and three specialty hospitals. Mass General Brigham is the largest hospital system-based research enterprise in the nation, with an annual research budget exceeding $2 billion. Its research enterprise is the top healthcare system recipient of National Institutes of Health funds, encompasses more than 14,0000 researchers and is home to over 2,700 active clinical trials.
“I can think of no better leader to guide our collaborative work across Mass General Brigham to fulfill our research and educational mission,” said Anne Klibanski, MD, president and CEO of Mass General Brigham. “Going forward, Paul’s leadership will be invaluable as we create and sustain an infrastructure that strengthens collaboration and progress for research-infused care that will continue to benefit patients.”
Since January, Anderson has led several transformative initiatives to elevate research and teaching across Mass General Brigham, with a particular focus on supporting enhanced collaboration toward greater impact for patients and the world. Anderson oversaw the launch and growth of the Gene and Cell Therapy Institute, a hub of innovation and collaboration that unites more than 400 researchers and clinicians dedicated to advancing gene and cell therapy. He also played a key role in the launch of the Gene Lay Institute of Immunology and Inflammation, a new organization that leverages a historic $100 million gift to Brigham and Women’s Hospital and brings together investigators from the Brigham, Massachusetts General Hospital and Harvard Medical School to drive clinical application of discoveries in immunology.
“We believe that in the next 5 to 10 years, many new therapies for our patients will come from gene and cell therapy discoveries and research endeavors across our hospitals,” said Anderson. “I'm thrilled to be able to put our vision into practice by supporting our investigators in moving discoveries toward new treatments for patients here and around the world.”
As Chief Academic Officer, Anderson will continue to oversee several key systemwide functions, including Human Subjects Affairs, Clinical Trials Office, Research Management, Research IS Computing, the Data Science Office, Personalized Medicine, Mass General Brigham’s Gene and Cell Therapy Institute, and Graduate Medical Education.
“Educating the next generation of researchers and clinicians is central to our mission,” said Anderson. “Providing a world-class education and training is a key part of who we are and what we do, providing the bedrock for our efforts to improve patient care and advance medical treatment.”
Anderson is a highly accomplished investigator with significant experience in teaching and training. He serves as Academic Dean for Mass General Brigham at Harvard Medical School and is the K. Frank Austen Professor of Medicine at Harvard Medical School. After graduating from the medical scientist training program at the New York University School of Medicine, Anderson came to Brigham and Women’s Hospital to complete an internship and residency in Internal Medicine and a fellowship in Rheumatology before launching his own lab at the Brigham in 1990. He later served as Associate Chief of the Division of Rheumatology, Inflammation, and Immunity and was appointed Chief Academic Officer at Brigham and Women's Hospital in 2015. As he assumes this new role as permanent Chief Academic Officer for Mass General Brigham, he will continue to provide leadership at Brigham and Women’s Hospital, serving as interim Chief Academic Officer there.
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-10-24
Researchers have identified buried kimberlite, the rocky home of diamonds, by testing the DNA of microbes in the surface soil.
These ‘biological fingerprints’ can reveal what minerals are buried tens of metres below the earth’s surface without having to drill. The researchers believe it is the first use of modern DNA sequencing of microbial communities in the search for buried minerals.
The research published this week in Nature Communications Earth and Environment represents a new tool for mineral exploration, where a full toolbox could save prospectors time and a lot of money, says co-author Bianca Iulianella Phillips, a doctoral candidate at ...
2023-10-24
Adding crushed volcanic rock to cropland could play a key role in removing carbon from the air. In a field study, scientists at the University of California, Davis, and Cornell University found the technology stored carbon in the soil even during an extreme drought in California. The study was published in the journal Environmental Research Communications.
Rain captures carbon dioxide from the air as it falls and reacts with volcanic rock to lock up carbon. The process, called rock weathering, can take millions of years ...
2023-10-24
She has explored the brain’s secrets for more than 50 years, delving deep into the genes, proteins and cells that help govern our emotions and moods, and our responses to pleasure and pain.
And today, Huda Akil, Ph.D., received the nation’s highest scientific honor – the National Medal of Science -- for those contributions and their impact on humankind’s understanding of depression, anxiety, addiction and more.
Akil, a neuroscientist at the University of Michigan Medical School and Michigan Neuroscience Institute, and her fellow awardees were honored at the White House in a ceremony ...
2023-10-24
Arizona Health Opportunities Pathways to Excellence, a program of the University of Arizona Health Sciences Office of Equity, Diversity and Inclusion, received a $3.2 million grant from the U.S. Department of Health and Human Services to help students from disadvantaged backgrounds achieve their dreams of becoming health care professionals.
Arizona Health Opportunities Pathways to Excellence, or AZ-HOPE, is a collaboration between academic and community partners to support students’ educational endeavors and help them overcome barriers on the pathway ...
2023-10-24
Tuesday, October 24, 2023, Cleveland: Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing a transcatheter aortic valve replacement (TAVR) at the same time as a left atrial appendage occlusion (LAAO) procedure using the Watchman™ device had similar outcomes when compared to patients getting TAVR in addition to medical therapy or blood thinners.
Results from the “Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement — ...
2023-10-24
Like several immunosuppressive biologics, the JAK inhibitor upadacitinib is also approved for the treatment of Crohn's disease. Commissioned by the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated in an early benefit assessment whether the drug offers an added benefit versus the appropriate comparator therapy to patients with moderate to severe active Crohn's disease who have had an inadequate response, lost response or are intolerant to conventional therapy or a biologic agent.
Therefore, an added benefit is not proven due to a lack of suitable study data. The ...
2023-10-24
UNIVERSITY PARK, Pa. — While governments may take the lead in planning and financing climate change adaptation measures, such as incentivizing green infrastructure, individuals currently are most often the ones implementing actions to adapt to climate change, according to new research. The analysis, conducted by an international consortium of researchers from 20 institutions, including Penn State, in 12 countries, published in Nature Climate Change.
“The evidence suggests that individuals and households are the primary adaptation actors — the ones actually implementing ways to ...
2023-10-24
Philadelphia, October 24, 2023 – Schizophrenia is a severe neuropsychiatric disease that remains poorly understood and treated. Schizophrenia onset is typically in adolescence or early adulthood, but its underlying causes are thought to involve neurodevelopmental abnormalities. Because human prenatal and postnatal brain tissue is exceedingly difficult to procure and therefore study, researchers have had limited opportunities to identify early disease mechanisms, especially during the critical prenatal period. Now, a pair of studies that appear in Biological Psychiatry, ...
2023-10-24
DURHAM, N.C. -- Curiosity paradoxically increases people’s patience for an answer, while simultaneously making them more eager to hear it, finds a new study by Duke neuroscientists.
The research might help teachers and students alike by describing a side of curiosity that encourages us to stay engaged instead of seeking immediate relief.
Die-hard fans of the Hulu show, "The Bear" are left on the edge of their seats each Sunday, wondering what's going to happen in the scrappy Chicago hotdog shop next week. But the new study from Duke helps explain why viewers may choose to avoid spoilers ...
2023-10-24
Scientists at the University of California, Davis, in partnership with the Mars Advanced Research Institute, have announced a significant breakthrough in the production of low-calorie sugar substitutes, such as allulose. This discovery could help address one of the primary obstacles to the widespread adoption of these alternatives: production costs.
Allulose, also known as D-psicose, is a naturally occurring rare sugar that provides a viable alternative to sucrose (table sugar). It has a similar taste, texture and functionality, making it an attractive option for those seeking to reduce their sugar intake. By activating a natural process in a microorganism, researchers have developed ...
LAST 30 PRESS RELEASES:
[Press-News.org] Mass General Brigham names Paul Anderson Chief Academic Officer
